CIK 0001372514 · Non-accelerated filer<br>Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980443284
- Phone
- 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-27 | ARMISTICE CAPITAL, LLC Director | Conversion | +852,500 | $4.80 | $4.1M | 4,199,101 |
| 2021-07-27 | ARMISTICE CAPITAL, LLC Director | Sale | −73,101 | $7.06 | $516K | 4,126,000 |
| 2021-07-27 | ARMISTICE CAPITAL, LLC Director | Sale | −461,797 | $6.45 | $3.0M | 3,664,203 |
| 2021-07-27 | ARMISTICE CAPITAL, LLC Director | Sale | −729,114 | $5.44 | $4.0M | 2,935,089 |
| 2021-07-27 | ARMISTICE CAPITAL, LLC Director | Sale | −532,069 | $4.59 | $2.4M | 2,403,020 |
| 2021-07-27 | ARMISTICE CAPITAL, LLC Director | Sale | −581,614 | $3.80 | $2.2M | 1,821,406 |
| 2021-07-27 | ARMISTICE CAPITAL, LLC Director | Conversion · Series C Convertible Preferred Stock | −4,092 | 0 | ||
| 2021-07-26 | Strem Brian M. President and CEO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-07-02 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −180 | $3.70 | $666 | 23,396 |
| 2021-07-02 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −160 | $3.70 | $592 | 15,443 |
Page 7 of 7 · 130 trades